Difference between revisions of "Defined daily dose"

From WikiProjectMed
Jump to navigation Jump to search
(→‎Use: added)
(Adding local short description: "Statistical measure of drug consumption", overriding Wikidata description "statistical measure of drug consumption" (Shortdesc helper))
Line 1: Line 1:
 +
{{short description|Statistical measure of drug consumption}}
 
The '''defined daily dose''' ('''DDD''') is a statistical measure of [[pharmaceutical drug|drug]] consumption, defined by the [[World Health Organization]] (WHO).  It is used to standardize the comparison of drug usage between different drugs or between different health care environments. The DDD is not to be confused with the [[therapeutic dose]] or with the dose actually prescribed by a physician for an individual person.<ref name="WHOCC">WHO Collaborating Centre for Drug Statistics Methodology (WHOCC): [http://www.whocc.no/ddd/definition_and_general_considera/ DDD Definition and general considerations]</ref>
 
The '''defined daily dose''' ('''DDD''') is a statistical measure of [[pharmaceutical drug|drug]] consumption, defined by the [[World Health Organization]] (WHO).  It is used to standardize the comparison of drug usage between different drugs or between different health care environments. The DDD is not to be confused with the [[therapeutic dose]] or with the dose actually prescribed by a physician for an individual person.<ref name="WHOCC">WHO Collaborating Centre for Drug Statistics Methodology (WHOCC): [http://www.whocc.no/ddd/definition_and_general_considera/ DDD Definition and general considerations]</ref>
  

Revision as of 12:19, 7 January 2020

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO). It is used to standardize the comparison of drug usage between different drugs or between different health care environments. The DDD is not to be confused with the therapeutic dose or with the dose actually prescribed by a physician for an individual person.[1]

The WHO's definition is: "The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults."[1]

Use

A common problem when comparing drugs is that different medications can be of different potency. For example, 20 mg of the beta blocker propranolol is less effective than 20 mg of the beta blocker bisoprolol.[2] To reflect this, the WHO has decided on a DDD for propranolol of 160 mg[3] and for bisoprolol of 10 mg.[4] Different people can still be prescribed higher or lower doses, for instance in children, people with liver or kidney impairment, patients with a combination therapy, or due to differences in drug metabolism between individuals or ethnicities (genetic polymorphism).[1]

The DDD system is most frequently used in academic articles and reports, and as a tool for comparison and control over nationwide total drug consumption. For example, the overall drug consumption of beta blockers can be measured in DDDs and compared between different countries, sexes or other populations.

The DDD can also be used to provide "a rough idea of the daily cost of utilizing a drug in a specific formulation" and "a rough idea of the cost differential between the two formulations of the same drug".[5] The cost per DDD is listed by the World Health Organization as one potential cost metric.[6]

Calculation

If the DDD for a certain drug is given, the number of DDDs used by an individual patient or (more commonly) by a collective of patients is as follows.

For example, the analgesic (pain reliever) paracetamol has a DDD of 3 g, which means that an average patient who takes paracetamol for its main indication, which is pain relief, uses 3 grams per day. This is equivalent to six standard tablets of 500 mg each. If a patient consumes 24 such tablets (12 g of paracetamol in total) over a certain span of time, this equals a consumption of four DDDs.

See also

References

  1. 1.0 1.1 1.2 WHO Collaborating Centre for Drug Statistics Methodology (WHOCC): DDD Definition and general considerations
  2. Mutschler, Ernst; Gerd Geisslinger; Heyo K. Kroemer; Monika Schäfer-Korting (1996). Arzneimittelwirkungen (in German) (7 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. pp. 289–90. ISBN 3-8047-1377-7.CS1 maint: unrecognized language (link)
  3. WHOCC: Propranolol
  4. WHOCC: Bisoprolol
  5. "Use of the World Health Organization Defined Daily Dose in Canadian Drug Utilization and Cost Analyses". pmprb-cepmb.gc.ca. 19 June 2014. Retrieved 6 January 2020.
  6. "Introduction to Drug Utilization Research: Chapter 2: Types of drug use information: 2.6 Drug costs". apps.who.int. Retrieved 6 January 2020.

External links